Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
Status:
Terminated
Trial end date:
2021-01-05
Target enrollment:
Participant gender:
Summary
This rollover study will provide open-label treatment with cenicriviroc and will assess the
long-term safety of continued treatment with cenicriviroc in participants who participated in
either the CENTAUR study 652-2-203 [NCT02217475] or the AURORA study [NCT03028740].